MktsMarkets

Milestone Pharmaceuticals Inc.
NASDAQ: MISTKey statistics
MIST News
Stories mentioning MIST from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 238.00 | 0.00 | ||||||
| Cost of Goods Sold | 14.00 | 0.00 | ||||||
| Gross Profit | 224.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 3,251 | 5,521 | 3,940 | 3,669 | 4,978 | 3,940 | 3,963 | 2,815 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (23,663) | (17,257) | (11,829) | (12,531) | (20,523) | (12,348) | (9,616) | (9,662) |
| Interest Income | 1,732 | 833.00 | 874.00 | 516.00 | 697.00 | 904.00 | 1,080 | 1,186 |
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (26,066) | (17,409) | (11,922) | (12,966) | (20,761) | (12,363) | (9,439) | (9,363) |
| Earnings Per Share (Basic) | (0.20) | (0.12) | (0.12) | (0.20) | (0.31) | (0.18) | (0.14) | (0.14) |
| Earnings Per Share (Diluted) | (0.20) | (0.12) | (0.12) | (0.20) | (0.31) | (0.18) | (0.14) | (0.14) |
| Weighted Average Shares Outstanding (Basic) | ||||||||
| Weighted Average Shares Outstanding (Diluted) | ||||||||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About MIST
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) is a stock listed on the Nasdaq Stock Market under the ticker symbol MIST. It last traded at $0.7600 (Nov 6, 2026, 9:30 AM ET), up 10.1% on the day. That gives Milestone Pharmaceuticals a market capitalisation of $90.9M.
Over the past 52 weeks MIST has traded between $0.6300 and $3.06.
Revenue for the quarter ended Mar 31, 2026 was $238.0K; a net loss of $26.1M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $238.0K | -$26.1M | -10952.1% |
| Dec 31, 2025 | — | -$17.4M | — |
| Sep 30, 2025 | — | -$11.9M | — |
| Jun 30, 2025 | — | -$13.0M | — |
From Milestone Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…